Barcelona, Spain

María Nieto Soler

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: María Nieto Soler. Retrieved from https://idiyas.com/inventor/maría-nieto-soler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of María Nieto Soler

Introduction

María Nieto Soler is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of cancer research through his innovative work in chemical entities. His dedication to advancing medical science is evident in his patented inventions.

Latest Patents

María Nieto Soler holds a patent for chemical entities that are selected from compounds of formula (I). These compounds, along with their pharmaceutically acceptable salts, solvates, and stereoisomers, serve as inhibitors of ATR and have potential applications in cancer treatment. The patent also includes pharmaceutical compositions of these chemical entities, combination products, and methods of treatment using these compositions.

Career Highlights

He is affiliated with the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, where he continues to contribute to groundbreaking research in oncology. His work focuses on developing therapeutic agents that can significantly impact cancer treatment.

Collaborations

María has collaborated with notable colleagues such as Joaquín Pastor Fernández and Oscar Fernández-Capetillo Ruiz. Their combined expertise enhances the research efforts in the field of cancer therapeutics.

Conclusion

María Nieto Soler's innovative work and patent in the field of chemical entities demonstrate his commitment to improving cancer treatment. His contributions are vital to the ongoing research and development in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…